Trinity Biotech (TRIB) Net Income towards Common Stockholders (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Net Income towards Common Stockholders (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 26,200.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -229.52% |
| Sep 30, 2024 | 31.04% |
| Jun 30, 2024 | -113.90% |
| Mar 31, 2024 | 40.93% |
| Dec 31, 2023 | 18.13% |
| Sep 30, 2023 | 63.35% |
| Jun 30, 2023 | -190.30% |
| Mar 31, 2023 | 37.19% |
| Dec 31, 2022 | -0.67% |
| Sep 30, 2022 | 1.59% |
| Jun 30, 2022 | 23.22% |
| Mar 31, 2022 | -276.32% |
| Dec 31, 2021 | -289.69% |
| Sep 30, 2021 | 251.42% |
| Jun 30, 2021 | -88.01% |
| Mar 31, 2021 | -51.83% |
| Dec 31, 2020 | -14.95% |
| Sep 30, 2020 | 499.78% |
| Jun 30, 2020 | -42.04% |
| Mar 31, 2020 | 82.01% |